Bidding 10-12 Sep 2025, price band ₹51–54, lot 2000 shares.
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 11 Sep | ₹0 | ₹54 | 0.00% |
| 10 Sep | ₹6 | ₹60 | 11.11% |
| 9 Sep | ₹3 | ₹57 | 5.56% |
| 8 Sep | ₹1 | ₹55 | 1.85% |
| 7 Sep | ₹0 | ₹54 | 0.00% |
After allotment
| Category | Times | Est. Allotment Chances* |
|---|---|---|
| HNIs (Total) | 1.48 | 67.6% |
| bHNI | 1.88 | 53.2% |
| sHNI | 0.66 | 100% |
| QIBs | 1 | - |
| Retail | 2.09 | 47.8% |
| Total | 1.83 | - |
*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.
Galaxy Medicare is a leading Indian manufacturer, trader, and exporter of medical devices, Plaster of Paris (POP) bandages, and surgical dressings, established in 1992. With over three decades of experience in the healthcare industry, the company operates through a diversified business model including in-house manufacturing, OEM production, institutional sales, exports, and trading. The company has built a strong reputation with 27 registered trademarks and serves government health departments, corporate hospitals, and private healthcare providers across India and international markets.